1. Home
  2. CRNC vs TBPH Comparison

CRNC vs TBPH Comparison

Compare CRNC & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cerence Inc.

CRNC

Cerence Inc.

HOLD

Current Price

$11.50

Market Cap

362.2M

Sector

Technology

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$18.12

Market Cap

993.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNC
TBPH
Founded
2020
2013
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
362.2M
993.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CRNC
TBPH
Price
$11.50
$18.12
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$11.50
$27.80
AVG Volume (30 Days)
2.0M
516.8K
Earning Date
11-19-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.58
Revenue
$251,781,000.00
$80,327,000.00
Revenue This Year
$27.55
$70.78
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$31.31
Revenue Growth
N/A
27.12
52 Week Low
$5.94
$7.90
52 Week High
$27.50
$20.33

Technical Indicators

Market Signals
Indicator
CRNC
TBPH
Relative Strength Index (RSI) 53.56 54.58
Support Level $9.56 $17.25
Resistance Level $13.17 $20.32
Average True Range (ATR) 0.67 0.73
MACD 0.12 -0.28
Stochastic Oscillator 47.47 30.62

Price Performance

Historical Comparison
CRNC
TBPH

About CRNC Cerence Inc.

Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: